Structure-activity relationships of HIV-1 PR inhibitors containing AHPBA .2. Modification of pyrrolidine ring at P1' proline

被引:16
|
作者
Komai, T
Higashida, S
Sakurai, M
Nitta, T
Kasuya, A
Miyamaoto, S
Yagi, R
Ozawa, Y
Handa, H
Mohri, H
Yasuoka, A
Oka, S
Nishigaki, T
Kimura, S
Shimada, K
Yabe, Y
机构
[1] SANKYO CO LTD,BIOL RES LABS,SHINAGAWA KU,TOKYO 140,JAPAN
[2] SANKYO CO LTD,EXPLORATORY CHEM RES LAB,SHINAGAWA KU,TOKYO 140,JAPAN
[3] TOKYO INST TECHNOL,FAC BIOSCI & BIOTECHNOL,MIDORI KU,YOKOHAMA,KANAGAWA 227,JAPAN
[4] UNIV TOKYO,INST MED SCI,MINATO KU,TOKYO 108,JAPAN
关键词
D O I
10.1016/0968-0896(96)00130-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Systematic replacement in the 3- or 4-position of the pyrrolidine ring at P1' proline was carried out. Compound 26, which has a C1 atom in the 4(S)-position was the most active among inhibitors substituted with other halogen atoms or other substituents. Furthermore, the replacement of the Z group in compound 26 with five- or six-membered fused aromatic heterocycle carbonyl groups produced more potent inhibitors. 7-Methoxybenzofuran-2-carbonyl derivative (44) was the best of these and showed K-i = 4.5 nM against HIV PR and IC(50)s 0.58 mu M and 0.06 mu M in chronic and acute infections, respectively. These results suggest that the combination of the 4(S)-Cl atom and fused bicyclic heterocycles may be effective in improving their cellular penetration. Copyright (C) 1996 Elsevier Science Ltd
引用
收藏
页码:1365 / 1377
页数:13
相关论文
共 50 条
  • [1] Structure-activity relationship of HIV-1 protease inhibitors containing AHPBA.: Part III:: Modification of P2 site
    Takashiro, E
    Watanabe, T
    Nitta, T
    Kasuya, A
    Miyamoto, S
    Ozawa, Y
    Yagi, R
    Nishigaki, T
    Shibayama, T
    Nakagawa, A
    Iwamoto, A
    Yabe, Y
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (05) : 595 - 604
  • [2] Structure-activity relationships of synthetic coumarins as HIV-1 inhibitors
    Kostova, I.
    Raleva, S.
    Genova, P.
    Argirova, R.
    [J]. BIOINORGANIC CHEMISTRY AND APPLICATIONS, 2006, 2006
  • [3] Allophenylnorstatine containing HIV-1 protease inhibitors: design, synthesis and structure-activity relationships for selected P2 ligands
    Abdel-Rahman, HMM
    Matsumoto, H
    Bekhit, AA
    Mimoto, T
    Nojima, S
    Takaku, H
    Kimura, T
    Akaji, K
    Kiso, Y
    [J]. PEPTIDE SCIENCE - PRESENT AND FUTURE, 1999, : 662 - 664
  • [4] Quantitative structure-activity relationships of HIV-1 integrase inhibitors of DKAs
    Shi Ya-Wei
    Liu Zhen-Ming
    Jin Hong-Wei
    Zhang Liang-Ren
    Zhang Li-He
    [J]. ACTA PHYSICO-CHIMICA SINICA, 2007, 23 (09) : 1393 - 1398
  • [5] HIV-1 PROTEASE INHIBITORS CONTAINING THE (HYDROXYETHYL) UREA ISOSTERE - MODIFICATION AT THE P1 POSITION
    FRESKOS, JN
    GETMAN, DP
    BRYANT, ML
    HOUSEMAN, KP
    MULLER, RA
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 136 - MEDI
  • [6] Allophenylnorstatine containing HIV-1 protease inhibitors:: design, synthesis and structure-activity relationships for selected P2 and P2′ ligands
    Bekhit, AA
    Matsumoto, H
    Abdel-Rahman, HMM
    Mimoto, T
    Nojima, S
    Takaku, H
    Kimura, T
    Akaji, K
    Kiso, Y
    [J]. PEPTIDE SCIENCE - PRESENT AND FUTURE, 1999, : 660 - 661
  • [7] Structure-activity relationship of HIV-1 protease inhibitors containing α-hydroxy-β-amino acids.: Detailed study of P1 site
    Takashiro, E
    Hayakawa, I
    Nitta, T
    Kasuya, A
    Miyamoto, S
    Ozawa, Y
    Yagi, R
    Yamamoto, I
    Shibayama, T
    Nakagawa, A
    Yabe, Y
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (09) : 2063 - 2072
  • [8] Structure-activity relationships of HIV-1 protease inhibitors containing gem-diaminoserine core unit
    Marastoni, M
    Bortolotti, F
    Salvadori, S
    Tomatis, R
    [J]. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1998, 48 (06): : 709 - 712
  • [9] Structure-activity relationships of novel HIV-1 protease inhibitors containing the 3-amino-2-chlorobenzoyl-allophenylnorstatine structure
    Mimoto, Tsutomu
    Nojima, Satoshi
    Terashima, Keisuke
    Takaku, Haruo
    Shintani, Makoto
    Hayashi, Hideya
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (03) : 1299 - 1308
  • [10] Hologram quantitative structure-activity relationships for a class of inhibitors of HIV-1 protease
    Ferreira, Leonardo G.
    Leitao, Andrei
    Montanari, Carlos A.
    Andricopulo, Adriano D.
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2007, 4 (05) : 356 - 364